// App-Quantinova.ai

1291 : Marqibo, Vincristine Sulfate Liposome Injection, for the Treatment of Advanced, Relapsed or Refractory Philadelphia Chromosome-Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) in an Adolescent Young Adult (AYA) Population

Researchers

Presenter

  • Gary J Schiller

Principal Investigators

  • Lloyd E. Damon

  • Wendy Stock

  • Steven E Coutre

  • Pamela Hsu

  • Lucy Prasad

  • Dan Douer

Medical Centers

  • University of Southern California, Los Angeles, CA

  • Department of Medicine, Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA

  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

  • The University of Chicago Medical Center, Chicago, IL

  • Department of Surgery, Gynecologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY

Locations

  • United States

Companies

  • Spectrum Pharmaceuti

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Vincristine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved